FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Merck sBLA for Keytruda for Rare Skin Cancer

[ Price : $8.95]

FDA accepts for priority review a Merck supplemental BLA seeking accelerated approval for Keytruda for treating adult and pediatri...

Pharmacokinetic Analyses Format and Content Guidance

[ Price : $8.95]

FDA issues a guidance to give sponsors or applicants the recommended format and content for submission of physiologically based ph...

AAV Gene Product Quantitation Workshop

[ Price : $8.95]

FDA announces a 12/7 public workshop on quantitation of AAV-based gene therapy products.

Vyaire Recalls Tri-Flo Suction System

[ Price : $8.95]

FDA says the Vyaire Medical recall of 2,150 units of its Tri-Flo suction system is Class 1.

HelloLife Recalls 4 Drug Products

[ Price : $8.95]

HelloLife recalls four homeopathic drug products due to microbial contamination.

Final Guide on Pharmacokinetic Analyses

[ Price : $8.95]

Federal Register notice: FDA releases a final guidance entitled Physiologically Based Pharmacokinetic Analyses Format and Content...

Janssen NDA for Treatment-resistant Depression

[ Price : $8.95]

Janssen files an NDA for esketamine nasal spray, indicated for treatment-resistant depression in adults.

Cardio/Renal Panel Renewed for 2 Years

[ Price : $8.95]

Federal Register notice: FDA announces the charter renewal for two years of its Cardiovascular and Renal Drugs Advisory Committee.

Endocrinologic/Metabolic Drugs Panel Renewed

[ Price : $8.95]

Federal Register notice: FDA renews for two years the charter of the Endocrinologic and Metabolic Drugs Advisory Committee.

Shared System REMS Comments

[ Price : $8.95]

Stakeholders express general support for an FDA guidance on shared system REMS and offer suggestions for changes to it.